%0 Journal Article
%9 ACL : Articles dans des revues avec comité de lecture répertoriées par l'AERES
%A Adamou, R.
%A Chenou, F.
%A Sadissou, I.
%A Sonon, P.
%A Dechavanne, C.
%A Djilali-Saiah, A.
%A Cottrell, Gilles
%A Le Port, A.
%A Massougbodji, A.
%A Remarque, E. J.
%A Luty, Adrian
%A Sanni, A.
%A Garcia, André
%A Migot Nabias, Florence
%A Milet, Jacqueline
%A Courtin, David
%T Plasmodium falciparum infection and age influence parasite growth inhibition mediated by IgG in Beninese infants
%D 2016
%L fdi:010066981
%G ENG
%J Acta Tropica
%@ 0001-706X
%K Plasmodium falciparum ; Malaria ; Antibodies ; IgG ; GIA ; Candidate vaccine antigens
%K BENIN
%M ISI:000377309400014
%P 111-119
%R 10.1016/j.actatropica.2016.03.020
%U https://www.documentation.ird.fr/hor/fdi:010066981
%> https://www.documentation.ird.fr/intranet/publi/2016/07/010066981.pdf
%V 159
%W Horizon (IRD)
%X Antibodies that impede the invasion of Plasmodium falciparum (P. falciparum) merozoites into erythrocytes play a critical role in anti-malarial immunity. The Growth Inhibition Assay (GIA) is an in vitro measure of the functional capacity of such antibodies to limit erythrocyte invasion and/or parasite growth. Up to now, it is unclear whether growth-inhibitory activity correlates with protection from clinical disease and there are inconsistent results from studies performed with GIA. Studies that have focused on the relationship between IgGs and their in vitro parasite Growth Inhibition Activity (GIAc) in infants aged less than two years old are rare. Here, we used clinical and parasitological data to precisely define symptomatic or asymptomatic infection with P. falciparum in groups of infants followed-up actively for 18 months post-natally. We quantified the levels of IgG1 and IgG3 directed to a panel of candidate P. falciparum vaccine antigens (AMA-1, MSP1, 2, 3 and GLURP) using ELISA and the functional activity of IgG was quantified using GIA. Data were then correlated with individuals' infection status. At 18 months of age, infants harbouring infections at the time of blood sampling had an average 19% less GIAc than those not infected (p = 0.004, multivariate linear regression). GIAc decreased from 12 to 18 months of age (p = 0.003, Wilcoxon matched pairs test). Antibody levels quantified at 18 months in infants were strongly correlated with their exposure to malarial infection, however GIAc was not correlated with malaria infectious status (asymptomatic and symptomatic groups). In conclusion, both infection status at blood draw and age influence parasite growth inhibition mediated by IgG in the GIA. Both factors must be taken into account when correlations between GIAc and anti-malarial protection or vaccine efficacy have to be made.
%$ 052 ; 050